long-term toxicity in hnscc
Published 7 years ago • 93 plays • Length 6:22Download video MP4
Download video MP3
Similar videos
-
6:19
nivolumab-related efficacy and toxicity in hnscc patients
-
4:24
historic perspective on recurrent hnscc
-
5:14
immunotherapy for recurrent hnscc
-
3:08
improved survival, toxicity & qol with pembrolizumab in head and neck cancer
-
5:34
pembrolizumab for recurrent hnscc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
3:14
treatments for head and neck cancer (squamous carcinoma tumor)
-
7:27
lung cancer: from the deadliest to the least aggressive forms
-
10:26
cetuximab or chemotherapy in hnscc?
-
8:56
cetuximab safety profile in head and neck cancer
-
11:57
immunotherapy in hnscc
-
1:27
dr. saba on immunotherapy/radiation combo in head and neck cancer
-
6:02
unmet needs in recurrent hnscc
-
6:59
surveillance in hnscc
-
29:00
head and neck toxicities
-
1:21
what is the future of hpv-positive and hpv-negative head and neck cancer management?
-
2:11
dr. weiss on next steps for immunotherapy in head and neck cancer
-
5:02
multimodality treatment for hnscc
-
6:47
surgery for locally advanced hnscc
-
4:38
emerging checkpoint inhibitors for hnscc
-
11:47
pembrolizumab in hnscc
-
12:46
head and neck cancer: treatment of advanced disease